Global Novel Coronavirus Drugs Market Report By Drugs (Remdesivir, Chloroquine and hydroxychloroquine, Ritonavir/lopinavir, Ritonavir/lopinavir + interferon beta, Others), By Age Group (<10 Years, 10-19 Years, 20-29 Years, 30-80 Years, >80 Years) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11211970
April 2020
Report Formats:

The global demand for Novel Coronavirus Drugs Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Novel Coronavirus Drugs is a set of drugs used to treat a new strain of Coronavirus called COVID -19. This virus affects the respiratory system and is spread from an infected person via droplets of his saliva or touch. An infected person can exhibit symptoms within 1-14 days since his exposure. The impact of COVID-19 among the global population is at an alarming scale and development of new drugs and vaccines take a long time. Globally doctors are working around the clock to use commercially available drugs to treat viruses affecting the respiratory system by repurposing them. Using deep learning techniques the interaction of drugs with the virus molecules are studied and drugs are being proposed to bring this pandemic under control. Hydroxychloroquine and chloroquine are the two drugs effectively used on patients so far.
 
Market Dynamics
 
The market for novel coronavirus drugs will be in mayhem until a specific drug for the complete treatment of the disease is available. The major drivers for this pandemic drug market are the effect of the virus on a larger scale and the increasing number of deaths even in developed countries like the USA. The drug market will see tremendous growth globally until the number of COVID -19 cases is reported as nil throughout the world. The main challenging factor is the fact that development and testing of suitable drugs and vaccines take a longer time than the rate at which this virus is having a devastating effect on humankind. Restrictions imposed by the WHO may have a restraining effect on the market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of novel coronavirus drugs.
 
Market Segmentation
 
The entire novel coronavirus drugs market has been sub-categorized into drugs and age group. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Drugs

  • Remdesivir
  • Chloroquine and hydroxychloroquine
  • Ritonavir/lopinavir
  • Ritonavir/lopinavir + interferon beta
  • Others
 
By Age Group
  • <10 Years
  • 10-19 Years
  • 20-29 Years
  • 30-80 Years
  • >80 Years
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for novel coronavirus drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Novel Coronavirus Drugs Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the novel coronavirus drugs market include CanSino Biologics Inc., Entos Pharmaceuticals, Inc., Gilead, Inovio, King Abdullah International Medical Research Center, National Institute of Allergy and Infectious Diseases, Naval Medical Research Center, Novavax, Philipps University Marburg Medical Center, SAB Biotherapeutics Inc.. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Novel Coronavirus Drugs Market
       2.2. Global Novel Coronavirus Drugs Market Snapshot
 
3 . NOVEL CORONAVIRUS DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Novel Coronavirus Drugs Market
       3.3. Market Restraints of Novel Coronavirus Drugs Market
       3.4. Opportunities of Novel Coronavirus Drugs Market
       3.5. Trends of Novel Coronavirus Drugs Market
       3.6. Porter’s Five Force Analysis of Novel Coronavirus Drugs Market
       3.7. Novel Coronavirus Drugs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drugs
           3.7.2 Market Attractive Analysis by Age Group
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Novel Coronavirus Drugs Value Chain Analysis
       4.2. Novel Coronavirus Drugs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Novel Coronavirus Drugs Raw Material Manufactures List
           4.2.3. Price Trend of Novel Coronavirus Drugs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL NOVEL CORONAVIRUS DRUGS MARKET ANALYSIS BY DRUGS
       5.1 Overview by Drugs
       5.2 Global Novel Coronavirus Drugs Market Analysis by Drugs
       5.3 Market Analysis of Remdesivir by Regions
       5.4 Market Analysis of Chloroquine and hydroxychloroquine by Regions
       5.5 Market Analysis of Ritonavir/lopinavir by Regions
       5.6 Market Analysis of Ritonavir/lopinavir + interferon beta by Regions
       5.7 Market Analysis of Others by Regions
 
6 . GLOBAL NOVEL CORONAVIRUS DRUGS MARKET ANALYSIS BY AGE GROUP
       6.1 Overview by Age Group
       6.2 Global Novel Coronavirus Drugs Market Analysis by Age Group
       6.3 Market Analysis of <10 Years  by Regions
       6.4 Market Analysis of 10-19 Years  by Regions
       6.5 Market Analysis of 20-29 Years  by Regions
       6.6 Market Analysis of 30-80 Years  by Regions
       6.7 Market Analysis of >80 Years by Regions
 
7 . GLOBAL NOVEL CORONAVIRUS DRUGS MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Novel Coronavirus Drugs Market Estimate by Market Segment
           7.3.3. North America Novel Coronavirus Drugs Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Novel Coronavirus Drugs Market Estimate by Market Segment
           7.4.3. Europe Novel Coronavirus Drugs Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Novel Coronavirus Drugs Market Estimate by Market Segment
           7.5.3. Asia Pacific Novel Coronavirus Drugs Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Novel Coronavirus Drugs Market Estimate by Market Segment
           7.6.3. Latin America Novel Coronavirus Drugs Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Novel Coronavirus Drugs Market Estimate by Market Segment
           7.7.3. Middle East & Africa Novel Coronavirus Drugs Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE NOVEL CORONAVIRUS DRUGS COMPANIES
       8.1. Novel Coronavirus Drugs Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF NOVEL CORONAVIRUS DRUGS INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. CanSino Biologics Inc.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Entos Pharmaceuticals, Inc.
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Gilead
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Inovio
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. King Abdullah International Medical Research Center
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. National Institute of Allergy and Infectious Diseases
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Naval Medical Research Center
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Novavax
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Philipps University Marburg Medical Center
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. SAB Biotherapeutics Inc.
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Novel Coronavirus Drugs Market Snapshot
  • Drivers of The Global Novel Coronavirus Drugs Market Impact Analysis
  • Restraints of The Global Novel Coronavirus Drugs Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in Remdesivir by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in Chloroquine and hydroxychloroquine by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in Ritonavir/lopinavir by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in Ritonavir/lopinavir + interferon beta by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in Others by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis by Age Group (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in <10 Years  by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in 10-19 Years  by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in 20-29 Years  by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in 30-80 Years  by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in >80 Years by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market by Geography (USD MN)
  • North America Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • North America Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • North America Novel Coronavirus Drugs Market Estimate by Country (USD MN)
  • United State Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • United State Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Rest of North America Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Rest of North America Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Europe Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Europe Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • United Kingdom Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • United Kingdom Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • France Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • France Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Germany Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Germany Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Rest of Europe Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Rest of Europe Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Asia Pacific Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Asia Pacific Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Asia Pacific Novel Coronavirus Drugs Market Estimate by Country (USD MN)
  • China Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • China Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Japan Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Japan Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • India Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • India Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Rest of Asia Pacific Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Rest of Asia Pacific Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Latin America Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Latin America Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Latin America Novel Coronavirus Drugs Market Estimate by Country (USD MN)
  • Brazil Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Brazil Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Rest of Latin America Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Rest of Latin America Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Middle East & Africa Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Middle East & Africa Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Middle East & Africa Novel Coronavirus Drugs Market Estimate by Country (USD MN)
  • Middle East Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Middle East Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Africa Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Africa Novel Coronavirus Drugs Market Estimate by Age Group (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Novel Coronavirus Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Novel Coronavirus Drugs Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drugs
  • Market Attractiveness Analysis by Age Group
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Novel Coronavirus Drugs Market Analysis by Drugs (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in Remdesivir by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in Chloroquine and hydroxychloroquine by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in Ritonavir/lopinavir by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in Ritonavir/lopinavir + interferon beta by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in Others by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis by Age Group (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in <10 Years  by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in 10-19 Years  by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in 20-29 Years  by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in 30-80 Years  by Geography (USD MN)
  • Global Novel Coronavirus Drugs Market Analysis in >80 Years by Geography (USD MN)
  • Latin America Novel Coronavirus Drugs Market by Revenue
  • Middle East & Africa Novel Coronavirus Drugs Market by Revenue
  • Recent Development in Novel Coronavirus Drugs Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials